The study of the prevalence of vitamin D۳ deficiency and its relationship with blood glucose level after coronary artery bypass graft operation among patients with diabetes

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 114

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CBJ-1-1_005

تاریخ نمایه سازی: 6 تیر 1401

Abstract:

Objectives: Nowadays, vitamin D۳ (VitD۳) deficiency is among the most common dietary deficiencies around the world. Researchers have paid more attention to VitD۳ because it is a vital element of the body and has a plausible relationship with various diseases such as diabetes mellitus type II. This study was conducted to examine the prevalence of vitamin D۳ deficiency and its relationship with blood sugar levels in people with diabetes undergoing coronary artery bypass grafting (CABG).Methods: An observational study was conducted in ۲۰۱۷ in Shahid Madani Hospital, Tabriz, Iran, for ۸ months. Due to the use of census sampling, only ۱۱۵ patients with diabetes and open-heart surgery were enrolled in the study. A questionnaire collected information on the participants' demographics, medical history, VitD۳ levels and blood glucose levels. Data were analyzed using SPSS ver. ۲۵. Independent t-test was used to compare quantitative data, and chi-square test was used to compare categorical variables. Results: One hundred and fifteen out of ۳۴۸ patients who had CABG surgery were diabetic. Moreover, ۲۴.۷% of patients with diabetes had VitD۳ deficiency. The results of the coefficient-correlation test indicated that there was a significant relationship between the mean blood glucose level and VitD۳ level (p < ۰.۰۵). Conclusions: The results of this study suggest that patients with diabetes can improve their blood glucose control after CABG surgery by taking sufficient VitD۳. Therefore, it should be considered as a principle of the hospital operation to prescribe VitD۳ prior to surgery for these patients.

Authors

Babak Nasiri

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Mohammad Ali Eghbal

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

Mohammadreza Taban Sadeghi

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Razieh Parizad

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Ali Asghar Darzi

Medical School, Babol University of Medical Sciences, Babol, Iran

Parisa Nazeri

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

Mohsen Abbasnezhad

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Naser Khezerlou Aghdam

Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran